Cargando…

Prognostic value of transglutaminase 2 in non-small cell lung cancer patients

Transglutaminase 2 (TG2) plays important roles in cell survival and cancer progression. In this study, we examined TG2 expression in specimen of 194 patients diagnosed with non-small cell lung cancer (NSCLC), and found that the TG2 gene expression was significantly higher in lung cancer tissues as c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chihong, Zhu, Yutian, Ling, Danying, Wan, Ruibin, Jiang, Huaying, Sheng, Linhui, Gu, Jianguo, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542209/ https://www.ncbi.nlm.nih.gov/pubmed/28715877 http://dx.doi.org/10.18632/oncotarget.17374

Ejemplares similares

Significance of Methylation of FBP1 Gene in Non-Small Cell Lung Cancer
por: Dong, Yao, et al.
Publicado: (2018)

Therapy Effects of Wogonin on Ovarian Cancer Cells
por: Ruibin, Jiang, et al.
Publicado: (2017)

Transglutaminase 2 Inhibitor KCC009 Induces p53-Independent Radiosensitization in Lung Adenocarcinoma Cells
por: Huayin, Sheng, et al.
Publicado: (2016)

Correlation of neuroendocrine features with prognosis of non-small cell lung cancer
por: Feng, Jianguo, et al.
Publicado: (2016)

Effect of Adjuvant Magnetic Fields in Radiotherapy on Non-Small-Cell Lung Cancer Cells In Vitro
por: Feng, Jianguo, et al.
Publicado: (2013)

Cardamonin induces G2/M phase arrest and apoptosis through inhibition of NF-κB and mTOR pathways in ovarian cancer
por: Ruibin, Jiang, et al.
Publicado: (2020)

Establishment and Characterization of a Highly Metastatic Ovarian Cancer Cell Line
por: Ruibin, Jiang, et al.
Publicado: (2018)

Serum high-density lipoprotein level and prognosis of ovarian cancer
por: Hongyan, Jiang, et al.
Publicado: (2023)

A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC–OXPHOS axis
por: Jiang, Ruibin, et al.
Publicado: (2023)

Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer
por: Choi, Chang-Min, et al.
Publicado: (2011)

Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
por: Zhao, Yanjie, et al.
Publicado: (2020)

Prognostic and predictive value of HURP in non-small cell lung cancer
por: Wang, Qi, et al.
Publicado: (2018)

The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China
por: Liu, Yifei, et al.
Publicado: (2018)

Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer
por: Sun, Lin, et al.
Publicado: (2020)

Prognostic value of pretreatment serum fibrinogen in young patients with small cell lung cancer: A cross‐sectional study
por: Tian, Juncai, et al.
Publicado: (2023)

SPARC expression and prognostic value in non-small cell lung cancer
por: Huang, Yan, et al.
Publicado: (2012)

Prognostic value of LIPC in non-small cell lung carcinoma
por: Alifano, Marco, et al.
Publicado: (2013)

Enhanced expression of cohesin loading factor NIPBL confers poor prognosis and chemotherapy resistance in non-small cell lung cancer
por: Xu, Weizhen, et al.
Publicado: (2015)

Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
por: Wan, Yanhui, et al.
Publicado: (2022)

Small Molecule Inhibitors Target the Tissue Transglutaminase and Fibronectin Interaction
por: Yakubov, Bakhtiyor, et al.
Publicado: (2014)

The prognostic value of the Naples prognostic score for patients with non-small-cell lung cancer
por: Peng, Si-Min, et al.
Publicado: (2022)

Prognostic value of TIM-1 expression in human non-small-cell lung cancer
por: Zheng, Xiao, et al.
Publicado: (2019)

Prognostic value of genomic damage in non-small-cell lung cancer.
por: de Juan, C., et al.
Publicado: (1998)

Prognostic value of AKT isoforms in non-small cell lung adenocarcinoma
por: Khurana, Sahil, et al.
Publicado: (2023)

SLC7A7 is a prognostic biomarker correlated with immune infiltrates in non-small cell lung cancer
por: Dai, Wumin, et al.
Publicado: (2021)

Transglutaminase-2: Nature’s Glue in Lung Fibrosis?
por: Sanders, Yan Y., et al.
Publicado: (2021)

The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis
por: Wang, Fei, et al.
Publicado: (2015)

Prognostic Value of Survivin in Patients with Non-Small Cell Lung Carcinoma: A Systematic Review with Meta-Analysis
por: Zhang, Lou Qian, et al.
Publicado: (2012)

The prognostic value of 4.1 mRNA expression in non-small cell lung cancer
por: Xiang, Yuying, et al.
Publicado: (2021)

Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value
por: Sun, Jian-guo, et al.
Publicado: (2009)

Prognostic value of metformin for non-small cell lung cancer patients with diabetes
por: Xu, Tongbai, et al.
Publicado: (2018)

Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer
por: Eberst, Guillaume, et al.
Publicado: (2022)

Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
por: Xu, Zihan, et al.
Publicado: (2019)

Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer
por: Zeng, Zhenguo, et al.
Publicado: (2020)

Implications of Transglutaminase-Mediated Protein Serotonylation in the Epigenetic Landscape, Small Cell Lung Cancer, and Beyond
por: Lin, Jason, et al.
Publicado: (2023)

Prognostic Value of Chromatin Structure Typing in Early-Stage Non-Small Cell Lung Cancer
por: Mao, Luning, et al.
Publicado: (2023)

The value of completion residual lung resection in ipsilateral recurrent non-small cell lung cancer
por: Yang, Yong, et al.
Publicado: (2022)

Expression and prognostic value of E2F3 transcription factor in non-small cell lung cancer
por: Wu, Lei, et al.
Publicado: (2021)

Promising prognostic value of Transglutaminase type 2 and its correlation with tumor-infiltrating immune cells in skin cutaneous melanoma
por: Muccioli, Silvia, et al.
Publicado: (2022)

Prognostic value of adjuvant therapy in T4 non‐small cell lung cancer: An inverse probability of treatment weighting analysis
por: Song, Ya‐ting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qr2i73cmh2o0u2tvqdcgr6n7kp